Article
CYP2D6 Protein Level Is the Major Contributor to Interindividual Variability in CYP2D6-Mediated Drug Metabolism in Healthy Human Liver Tissue.
Clinical pharmacology and therapeutics - 1 Nov 2018
Ning Miaoran, Duarte Julio D, Rubin Leah H, Jeong Hyunyoung
Abstract excerpt
CYP2D6 genetic polymorphisms are considered a major contributor to the large interindividual variability in CYP2D6-mediated drug metabolism, but fail to explain a significant portion of the variability. The aim of this study was to assess the ability of the CYP2D6 activity score (AS) estimated from CYP2D6 genotype to predict CYP2D6 expression and enzyme activity. The CYP2D6 gene region was sequenced in 115...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
